U.S. Hemp Roundtable Requests FDA Issue Policy Of Enforcement Discretion For CBD

1w
2m read
Summary

Today, the U.S. Hemp Roundtable sent a letter to FDA Commissioner Robert Califf requesting the immediate issue of an enforcement discretion policy for dietary supplements containing hemp-derived CBD and other cannabinoids. The FDA has recently announced its intent to exercise enforcement discretion with respect to the sale and distribution of certain products that contain N-acetyl-L-cysteine (NAC) that are labeled as dietary supplements, along with the agency’s consideration of a rulemaking to allow the use of NAC in dietary supplements. We ask for your help to break this stalemate, and we stand by to participate in productive negotiations with your staff to come up with solutions that best protect American consumers.” Read the letter here. Unfortunately, the agency has been unwilling to meet with us to discuss legislative options,” Miller states in the letter. “At the same time, we have been told FDA is urging congressional staff not to proceed with existing legislation.

Article Preview

Today, the U.S. Hemp Roundtable sent a letter to FDA Commissioner Robert Califf requesting the immediate issue of an enforcement discretion policy for dietary supplements containing hemp-derived CBD and other cannabinoids.

Read the letter here.

The FDA has recently announced its intent to exercise enforcement discretion with respect to the sale and distribution of certain products that contain N-acetyl-L-cysteine (NAC) that are labeled as dietary supplements, along with the agency’s consideration...

Read the full article @ Cannabis Law Report